NeutraKine FLT3 Ligand Monoclonal antibody
NeutraKine FLT3 Ligand Monoclonal Antibody for ELISA, Neutralization
Host / Isotype
Mouse / IgG1
Reactivity
Human
Applications
ELISA, Neutralization
Conjugate
Unconjugated
CloneNo.
3E1A3
Cat no : 69032-1-Ig
Synonyms
Validation Data Gallery
| Neutralization | OCI-AML5 |
Product Information
69032-1-Ig targets NeutraKine FLT3 Ligand in ELISA, Neutralization applications and shows reactivity with Human samples.
| Tested Reactivity | Human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen | human NeutraKine FLT3 Ligand protein HZ-1151 相同性解析による交差性が予測される生物種 |
| Full Name | fms-related tyrosine kinase 3 ligand |
| Gene symbol | FLT3 Ligand |
| Gene ID (NCBI) | 2323 |
| Conjugate | Unconjugated |
| Form | Lyophilized Powder |
| Purification Method | Protein G purification |
| Storage Buffer | Sterile PBS. |
| Endotoxin | <0.1 EU/μg |
| Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
| Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Background Information
The FMS-related tyrosine kinase 3 (FLT3) ligand (FLT3LG), a growth factor, is mainly derived from lymphocytes in the tumor microenvironment. It binds to FLT3 on DCs to enhance their differentiation and expansion. Therefore, it may assist DCs in tumor antigen presentation and antitumor immune response. In addition, mature DCs express FLT3 and proliferate massively under the trigger of FLT3LG.
This antibody is used to neutralize the bioactivity of FLT3 Ligand.
